Skip to main content

BIO-TECHNE Corp ratios

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

In fiscal 2026 (the year to 30 Jun 2026), BIO-TECHNE Corp had an operating margin of 20.7%, a return on equity of 9.0%, a return on invested capital of 8.5%.

From BIO-TECHNE Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026.

Annual

BIO-TECHNE Corp ratios, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Gross margin78.8%79.6%77.6%75.0%74.4%70.3%67.9%67.5%66.5%67.2%66.3%65.4%68.0%68.4%67.7%66.4%64.8%65.8%
Operating margin57.1%58.1%56.2%52.8%51.0%44.7%32.5%30.2%21.4%21.2%20.5%21.3%25.5%26.8%26.3%17.8%8.4%20.7%
Net margin39.9%40.8%38.7%35.7%36.2%31.0%23.8%20.9%13.5%19.6%13.5%31.0%15.1%24.6%25.1%14.5%6.0%15.0%
Free cash flow margin39.7%39.6%42.6%38.4%32.6%34.4%26.4%25.5%22.8%23.2%21.9%20.8%33.1%25.4%19.0%20.4%21.0%21.7%
Return on equity23.1%22.9%20.6%17.8%15.9%14.5%13.1%12.1%8.3%12.4%8.6%18.0%9.5%16.7%15.6%8.3%3.7%9.0%
Return on assets25.2%22.1%19.5%17.2%14.8%13.4%10.7%9.7%6.1%6.8%7.2%6.7%10.4%11.4%10.2%7.0%2.9%7.4%
Return on capital employed—31.2%29.6%25.9%22.2%20.2%15.8%14.3%9.7%9.3%8.9%8.5%11.8%14.0%12.9%8.2%4.2%10.5%
Return on invested capital38.3%32.5%27.0%26.4%26.8%24.8%14.8%11.2%7.3%8.2%8.5%7.9%12.4%13.5%11.8%7.8%3.2%8.5%
Current ratio—11.8112.679.6912.7617.796.244.692.575.014.054.883.353.444.843.873.464.55
Debt to equity—————0.000.090.100.360.310.430.310.270.190.230.200.230.14
Net debt / EBITDA—————−2.03−0.21−0.021.030.781.510.680.580.200.620.841.330.07
Interest coverage——————95.2286.1516.3813.376.768.2017.0126.2326.6613.1312.0226.16
Cash conversion99.5%97.1%110%107%89.8%111%111%122%169%118%163%66.9%219%103%75.8%140%350%145%
Dividend payout26.8%35.0%35.3%36.5%38.6%40.9%43.7%45.6%62.2%38.0%50.3%21.3%35.3%18.4%17.6%30.0%68.7%27.5%
SBC / Revenue0.6%0.4%0.4%—0.6%1.0%1.3%1.9%2.6%4.4%4.5%4.4%5.3%3.8%3.5%3.3%3.3%3.4%

Quarterly

BIO-TECHNE Corp ratios, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Gross margin64.8%67.4%66.4%63.2%65.3%67.9%62.7%65.6%64.6%66.9%65.8%65.6%
Operating margin13.9%22.1%15.0%13.8%16.0%12.2%−7.5%16.6%18.4%24.2%23.1%12.2%
Net margin10.1%16.2%13.3%11.6%11.7%7.1%−5.6%13.3%12.8%16.4%17.0%9.4%
Free cash flow margin25.0%21.3%18.8%18.9%26.1%9.8%29.4%7.8%25.9%24.9%27.1%22.4%
Return on equity1.4%2.4%2.0%1.6%1.7%1.1%−0.9%1.9%1.9%2.4%2.6%1.3%
Return on assets1.1%2.0%1.7%1.2%1.4%0.9%−0.7%1.5%1.6%2.1%2.2%1.1%
Return on capital employed1.5%2.6%1.8%1.5%1.9%1.6%−1.0%2.0%2.3%3.1%3.1%1.6%
Return on invested capital1.3%2.2%1.8%1.4%1.6%1.0%−0.8%1.7%1.8%2.4%2.6%1.4%
Current ratio4.374.083.874.563.943.713.464.224.544.494.552.28
Debt to equity0.280.250.200.190.190.210.230.200.170.140.140.13
Net debt / EBITDA6.383.713.613.102.924.2786.703.472.250.810.25−1.07
Interest coverage8.7816.7318.2618.3822.0819.29−10.9616.2425.0931.4334.9916.87
Cash conversion249%132%142%163%222%137%−527%58.2%201%152%159%238%
Dividend payout45.7%25.6%31.1%37.8%36.5%55.7%—32.6%32.8%24.5%22.8%44.4%
SBC / Revenue4.7%2.7%2.3%3.5%5.0%3.6%1.4%4.1%4.7%3.4%1.6%4.5%

The main figures as JSON and plain text. See data and methodology.

TECH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.